Targeted therapy in Ewing sarcoma.

about

IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine

P2860

Q35717574-09638A9F-4361-4753-B318-57F070603302 Q35987417-282891E3-3AAF-4DC1-8A5E-68B4DA5289E9

P2860

Targeted therapy in Ewing sarcoma.

Item

http://www.wikidata.org/entity/Q36011879

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Targeted therapy in Ewing sarcoma.

@ast

Targeted therapy in Ewing sarcoma.

@en

type

Item

label

Targeted therapy in Ewing sarcoma.

@ast

Targeted therapy in Ewing sarcoma.

@en

prefLabel

Targeted therapy in Ewing sarcoma.

@ast

Targeted therapy in Ewing sarcoma.

@en

P1476

Targeted therapy in Ewing sarcoma.

@en

P2093

A Lissat

http://www.w3.org/2001/XMLSchema#string

M M Chao

http://www.w3.org/2001/XMLSchema#string

U Kontny

http://www.w3.org/2001/XMLSchema#string

P2860

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

A new member of the ETS family fused to EWS in Ewing tumors

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma

Insulin and insulin-like growth factor signalling in neoplasia

The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function

Optimising chronic myeloid leukaemia therapy in the face of resistance to tyrosine kinase inhibitors--a synthesis of clinical and laboratory data.

Apoptosis control by death and decoy receptors.

EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.

ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.

P304

609439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5402/2012/609439

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225294138

http://www.w3.org/2001/XMLSchema#string

P698

22690342

http://www.w3.org/2001/XMLSchema#string

P932

3368441

http://www.w3.org/2001/XMLSchema#string

Targeted therapy in Ewing sarcoma.

about

P2860

P2860

Targeted therapy in Ewing sarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932